ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Ajanta Pharma (AJANTPHARM) Technical (Analysis) Reports Ajanta Pharma ["Technical Analysis"] Reports -NSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Ajanta Pharma (AJANTPHARM)

Technical Analysis Report for NSE stock AJANTPHARM Ajanta Pharma. Dated: 06 Feb 2026 Updated Daily. Stock trades under Pharmaceuticals in NSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NSE stock AJANTPHARM Ajanta Pharma then click here. or read Experts views on Ajanta Pharma or Forecast & share price targets of Ajanta Pharma

Ajanta Pharma Opened at 2828.30 and Closed at: 2852.70, which is 1.24% of previous session's close. It moved within a range of 2788.00 and 2866.00
The session was a Bullish session with an average volume of 107572, which is 7.79% of previous session's volumes.

  • There is some positive change in the short term trend, but its too soon to jump onto conclusions.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 3 days back on short term averages

Support for tomorrow is 2820.35 and resistance for tomorrow is 2898.35
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2805.13, 2757.57 resistance for tomorrow's hourly charts is 2883.13, 2913.57

10 Day SMA for Ajanta Pharma (AJANTPHARM) is 2785.77 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Ajanta Pharma (AJANTPHARM) is 2748.49 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Ajanta Pharma (AJANTPHARM) is 2714.26 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 2598.63 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Ajanta Pharma is 2611.19 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Ajanta Pharma is at 2748.49 and 200 DMA is at 2611.19, while 50 DMA and 100 DMA are at 2714.26 and 2598.63 respectively

Ajanta Pharma (AJANTPHARM) moving average of 20 SMA is at 2748.49 and 20 EMA is at 2772.99

Ajanta Pharma (AJANTPHARM) moving average of 50 SMA is at 2714.26 and 50 EMA is at 2714.57

Ajanta Pharma (AJANTPHARM) moving average of 100 SMA is at 2598.63 and 100 EMA is at 2661.98

Ajanta Pharma (AJANTPHARM) moving average of 200 SMA is at 2611.19 and 200 EMA is at 2658.87

Wanbury has performed better than Ajanta Pharma in short term. You could have earned much better returns by investing in Wanbury, about 8.9% more returns!

Ajanta Pharma has performed better than Themis Medicare in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Suven Life in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Strides Arcolab in short term. Holding Ajanta Pharma could be a better choice for now!

Sun Pharma has performed better than Ajanta Pharma in short term. You could have earned much better returns by investing in Sun Pharma, about 1.93% more returns!

Ajanta Pharma has performed better than Sms Pharmaceuticals in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Sun Pharmaceuticals in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Divi S in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Torrent Pharmaceuticals in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Alembic Pharmaceuticals in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Gufic Biosciences in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Jagsonpal Pharmaceuticals in short term. Holding Ajanta Pharma could be a better choice for now!

Kilitch Drugs has performed better than Ajanta Pharma in short term. You could have earned much better returns by investing in Kilitch Drugs, about 3.75% more returns!

Ajanta Pharma has performed better than Lincoln Pharma in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Morepen Laboratories in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Neuland Laboratories in short term. Holding Ajanta Pharma could be a better choice for now!

Ajanta Pharma has performed better than Pfizer in short term. Holding Ajanta Pharma could be a better choice for now!

Shilpa Medicare has performed better than Ajanta Pharma in short term. You could have earned much better returns by investing in Shilpa Medicare, about 1.53% more returns!

Ajanta Pharma Technical analysis of indicators

Price action analysis of Ajanta Pharma (AJANTPHARM) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Ajanta Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Ajanta Pharma in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Ajanta Pharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Ajanta Pharma in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Ajanta Pharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2797.6 and Ajanta Pharma AJANTPHARM stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Ajanta Pharma AJANTPHARM stock. Volume based technical analysis of Ajanta Pharma AJANTPHARM stock is negative.

Ajanta Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NSE stock AJANTPHARM Ajanta Pharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AJANTPHARM Experts View which covers a lot of information including buying and selling signals

AJANTPHARM future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Ajanta Pharma or View Candle Stick Charts here

Chart Ajanta Pharma (AJANTPHARM)  Technical (Analysis) Reports Ajanta Pharma [

Videos related to: Ajanta Pharma (AJANTPHARM) Technical (Analysis) Reports Ajanta Pharma ["Technical Analysis"] Reports -NSE Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Ajanta Pharma (AJANTPHARM)  Technical (Analysis) Reports Ajanta Pharma [

 

Back to top